97 related articles for article (PubMed ID: 29141792)
1. CD25 gene polymorphism and multiple sclerosis.
Alsahebfosoul F; Salehi R; Ghaffari S; Jahanbani-Ardakani H; Etemadifar M; Kazemi M; Abtahi SH
Mult Scler Relat Disord; 2017 Nov; 18():117-118. PubMed ID: 29141792
[No Abstract] [Full Text] [Related]
2. Genomewide study of multiple sclerosis.
Matesanz F; Fernández O; Alcina A
N Engl J Med; 2007 Nov; 357(21):2200; author reply 2200-1. PubMed ID: 18038462
[No Abstract] [Full Text] [Related]
3. Genomewide study of multiple sclerosis.
Ramagopalan SV; Anderson C; Sadovnick AD; Ebers GC
N Engl J Med; 2007 Nov; 357(21):2199-200; author reply 2200-1. PubMed ID: 18032773
[No Abstract] [Full Text] [Related]
4. Susceptibility to multiple sclerosis: the role of interleukin genes.
Marrosu MG
Lancet Neurol; 2007 Oct; 6(10):846-7. PubMed ID: 17884670
[No Abstract] [Full Text] [Related]
5. Old suspects found guilty--the first genome profile of multiple sclerosis.
Peltonen L
N Engl J Med; 2007 Aug; 357(9):927-9. PubMed ID: 17660531
[No Abstract] [Full Text] [Related]
6. IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.
Matesanz F; Caro-Maldonado A; Fedetz M; Fernández O; Milne RL; Guerrero M; Delgado C; Alcina A
J Neurol; 2007 May; 254(5):682-4. PubMed ID: 17420929
[No Abstract] [Full Text] [Related]
7. Interleukin 2 receptor α gene polymorphism and risk of multiple sclerosis: a meta-analysis.
Wang LM; Zhang DM; Xu YM; Sun SL
J Int Med Res; 2011; 39(5):1625-35. PubMed ID: 22117963
[TBL] [Abstract][Full Text] [Related]
8. Risk alleles for multiple sclerosis identified by a genomewide study.
; Hafler DA; Compston A; Sawcer S; Lander ES; Daly MJ; De Jager PL; de Bakker PI; Gabriel SB; Mirel DB; Ivinson AJ; Pericak-Vance MA; Gregory SG; Rioux JD; McCauley JL; Haines JL; Barcellos LF; Cree B; Oksenberg JR; Hauser SL
N Engl J Med; 2007 Aug; 357(9):851-62. PubMed ID: 17660530
[TBL] [Abstract][Full Text] [Related]
9. IL2RA gene polymorphism rs2104286 A>G seen in multiple sclerosis is associated with intermediate uveitis: possible parallel pathways?
Lindner E; Weger M; Steinwender G; Griesbacher A; Posch U; Ulrich S; Wegscheider B; Ardjomand N; El-Shabrawi Y
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8295-9. PubMed ID: 21911588
[TBL] [Abstract][Full Text] [Related]
10. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
[TBL] [Abstract][Full Text] [Related]
11. Relationship between soluble CD25 and gene expression in healthy individuals and patients with multiple sclerosis.
Buhelt S; Ratzer RL; Christensen JR; Börnsen L; Sellebjerg F; Søndergaard HB
Cytokine; 2017 May; 93():15-25. PubMed ID: 28511943
[TBL] [Abstract][Full Text] [Related]
12. Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA.
Matiello M; Weinshenker BG; Atkinson EJ; Schaefer-Klein J; Kantarci OH
Mult Scler; 2011 May; 17(5):634-6. PubMed ID: 21239413
[TBL] [Abstract][Full Text] [Related]
13. Genomewide study of multiple sclerosis.
Chaudhuri A; Behan PO
N Engl J Med; 2007 Nov; 357(21):2200; author reply 2200-1. PubMed ID: 18038461
[No Abstract] [Full Text] [Related]
14. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
Weber F; Fontaine B; Cournu-Rebeix I; Kroner A; Knop M; Lutz S; Müller-Sarnowski F; Uhr M; Bettecken T; Kohli M; Ripke S; Ising M; Rieckmann P; Brassat D; Semana G; Babron MC; Mrejen S; Gout C; Lyon-Caen O; Yaouanq J; Edan G; Clanet M; Holsboer F; Clerget-Darpoux F; Müller-Myhsok B
Genes Immun; 2008 Apr; 9(3):259-63. PubMed ID: 18354419
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans.
Stanković A; Dincić E; Ristić S; Lovrecić L; Starcević Cizmarević N; Djurić T; Sepcić J; Kapović M; Raicević R; Peterlin B; Alavantić D; Zivković M
Mult Scler; 2010 May; 16(5):533-6. PubMed ID: 20194581
[TBL] [Abstract][Full Text] [Related]
16. Risk alleles for multiple sclerosis in multiplex families.
D'Netto MJ; Ward H; Morrison KM; Ramagopalan SV; Dyment DA; DeLuca GC; Handunnetthi L; Sadovnick AD; Ebers GC
Neurology; 2009 Jun; 72(23):1984-8. PubMed ID: 19506219
[TBL] [Abstract][Full Text] [Related]
17. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in interleukin 7 receptor α chain (IL-7Ra) are associated with multiple sclerosis risk and disability progression in Central European Slovak population.
Čierny D; Hányšová S; Michalik J; Kantorová E; Kurča E; Škereňová M; Lehotský J
J Neuroimmunol; 2015 May; 282():80-4. PubMed ID: 25903732
[TBL] [Abstract][Full Text] [Related]
19. Analysis of variation in the IL7RA and IL2RA genes in atopic dermatitis.
Hoffjan S; Beygo J; Akkad DA; Parwez Q; Petrasch-Parwez E; Epplen JT
J Dermatol Sci; 2009 Aug; 55(2):138-40. PubMed ID: 19523791
[No Abstract] [Full Text] [Related]
20. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
Rubio JP; Stankovich J; Field J; Tubridy N; Marriott M; Chapman C; Bahlo M; Perera D; Johnson LJ; Tait BD; Varney MD; Speed TP; Taylor BV; Foote SJ; Butzkueven H; Kilpatrick TJ
Genes Immun; 2008 Oct; 9(7):624-30. PubMed ID: 18650830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
